1. American Joint Committee on Cancer (1992). Manual for Staging of Cancer, 4th edn, Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds)Lippincott: Philadelphia.
2. Ardizzoni, A, Fusco, V, Gulisano, M, Pronzato, P, Bracco, F, Capaccio, A, Pastorino, G, Nosenzo, M, Felletti, R, Fabiano, F & Rosso, R (1987). Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep 71: 1311–1312.
3. Bonomi, P & Penfield, FL (1997). Postoperative and preoperative chemotherapy for non-small-cell lung cancer. Cancer Control, J Moffitt Cancer Center 4: 297–306.
4. Calabresi, F, Papaldo, P, Marolla, P, Lopez, M, Vici, P, Di Lauro, L, Pellegrini, P, Foggi, CM, Lepidini, G, Antimi, M, Terzoli, E & Barone, C (1995). Different schedules of G-CSF in adjuvant breast cancer therapy with high-dose epirubicin + cyclophosphamide ± lonidamine. Proc Am Soc Clin Oncol 14: 698 (abstract).
5. Choi, NC (1983). Curative radiation therapy for unresectable non-small-cell carcinoma of the lung: indications, techniques, results. In: Thoracic Oncology, Choi NC, Grillo HC(eds) Raven: New York, pp. 163–199.